This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.
23andMe CEO Anne Wojcicki has submitted a proposal to take the genetic testing c...
Every weekday, the Investing Club releases the Homestretch; an actionable aftern...
Neuralink competitor Synchron announces integration with Apple Vision Pro.
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 bill...
The new test could increase the number of people screened for colorectal cancer,...
The trades come ahead of a busy week of earnings for the Investing Club portfolio.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
These are JPMorgan's top drug picks heading into earnings.
Every weekday, the Investing Club releases the Homestretch; an actionable aftern...
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Dexcom, which had its stock market debut in 2005, had its worst day ever after l...
Dexcom issued disappointing results and guidance, which the company attributed i...
Yuri Khodjamirian, fund manager at Tema ETFs, says there's a "valuation opportun...
GE HealthCare and AWS team up to build generative AI applications for medical use
Health authorities in the southern Indian state of Kerala are on high alert for ...
The U.K.'s health regulator on Tuesday approved the use of Novo Nordisk's Wegovy...